180 related articles for article (PubMed ID: 24411020)
1. Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme.
Ali AN; Ogunleye T; Hardy CW; Shu HK; Curran WJ; Crocker IR
Radiat Oncol; 2014 Jan; 9():20. PubMed ID: 24411020
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
3. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
[TBL] [Abstract][Full Text] [Related]
6. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
[TBL] [Abstract][Full Text] [Related]
7. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
[TBL] [Abstract][Full Text] [Related]
8. Role of hippocampal location and radiation dose in glioblastoma patients with hippocampal atrophy.
Le Fèvre C; Cheng X; Loit MP; Keller A; Cebula H; Antoni D; Thiery A; Constans JM; Proust F; Noel G
Radiat Oncol; 2021 Jun; 16(1):112. PubMed ID: 34158078
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy.
Nguyen D; Rwigema JC; Yu VY; Kaprealian T; Kupelian P; Selch M; Lee P; Low DA; Sheng K
Radiat Oncol; 2014 Nov; 9():239. PubMed ID: 25377756
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
11. Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost.
Ken S; Vieillevigne L; Franceries X; Simon L; Supper C; Lotterie JA; Filleron T; Lubrano V; Berry I; Cassol E; Delannes M; Celsis P; Cohen-Jonathan EM; Laprie A
Radiat Oncol; 2013 Jan; 8():1. PubMed ID: 23280007
[TBL] [Abstract][Full Text] [Related]
12. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
Yuen AHL; Wu PM; Li AKL; Mak PCY
Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
14. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.
Paulsson AK; McMullen KP; Peiffer AM; Hinson WH; Kearns WT; Johnson AJ; Lesser GJ; Ellis TL; Tatter SB; Debinski W; Shaw EG; Chan MD
Am J Clin Oncol; 2014 Apr; 37(2):177-81. PubMed ID: 23211224
[TBL] [Abstract][Full Text] [Related]
15. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
16. Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
Piroth MD; Galldiks N; Pinkawa M; Holy R; Stoffels G; Ermert J; Mottaghy FM; Shah NJ; Langen KJ; Eble MJ
Radiat Oncol; 2016 Jun; 11():87. PubMed ID: 27342976
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme.
Chan MF; Schupak K; Burman C; Chui CS; Ling CC
Med Dosim; 2003; 28(4):261-5. PubMed ID: 14684191
[TBL] [Abstract][Full Text] [Related]
18. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging.
Wang BH; Hua W; Gu X; Wang XL; Li J; Liu LQ; Huang YX
Australas Phys Eng Sci Med; 2015 Dec; 38(4):767-75. PubMed ID: 26577714
[TBL] [Abstract][Full Text] [Related]
20. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
Morganti AG; Balducci M; Salvati M; Esposito V; Romanelli P; Ferro M; Calista F; Digesù C; Macchia G; Ianiri M; Deodato F; Cilla S; Piermattei A; Valentini V; Cellini N; Cantore GP
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):92-7. PubMed ID: 19683876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]